Extended Data Table 1.
NED | EH only# | LM>6mo | LM<6mo | p value | |||||
---|---|---|---|---|---|---|---|---|---|
Patients in group (% all) | 9 | 24% | 9 | 11% | 13 | 20% | 10 | 22% | |
Male | 6 | 67% | 5 | 56% | 10 | 77% | 6 | 60% | 0.732^1 |
Age - Median (Range) | 65.1 | (49-83.4) | 71.6 | (58.6-87.0) | 67.5 | (57.8-81.1) | 67.7 | (51.7-77.1) | 0.545^2 |
BMI - Median (Range) | 27.9 | (24.1-35.0) | 32.1 | (22.3-37.2) | 25.7 | (19.5-39.0) | 25.5 | (20.0-32.4) | 0.317 ^2 |
Biliary obstruction * | 4 | 44% | 5 | 56% | 7 | 54% | 8 | 80% | 0.426 ^1 |
Preop. biliary drainage | 4 | 44% | 4 | 44% | 4 | 31% | 4 | 40% | 0.897 ^1 |
Preop CA19-9 - Median (Range) | 90 | (<1-130) | 147 | (3-463) | 211.5 | (64-1406) | 195 | (35-1132) | 0.368 ^4 |
Differentiation | 0.020 ^ 4 | ||||||||
Well | 2 | 22% | 0 | 0% | 0 | 0% | 0 | 0% | |
Moderate | 5 | 56% | 7 | 78% | 8 | 67% | 4 | 40% | |
Poor | 2 | 22% | 2 | 22% | 4 | 33% | 6 | 60% | |
T-stage (per AJCC 8th ed.) | 0.652 ^4 | ||||||||
1 (<2cm) | 1 | 11% | 1 | 11% | 0 | 0% | 0 | 0% | |
2 (>2 and <4cm) | 6 | 67% | 5 | 56% | 9 | 69% | 8 | 80% | |
3(>4cm) | 2 | 22% | 2 | 22% | 4 | 31% | 2 | 20% | |
4 (invasion of great vessels) | 0 | 0% | 1 | 11% | 0 | 0% | 0 | 0% | |
N-stage (per AJCC 8th ed.) | 6 | 67% | 8 | 89% | 8 | 61% | 6 | 60% | 0.286 ^4 |
0 (-ve LNs) | 3 | 33% | 1 | 11% | 5 | 39% | 4 | 40% | |
1 (1-3 +ve LNs) | 3 | 33% | 2 | 22% | 4 | 31% | 4 | 40% | |
2 (>3 +ve LNs) | 3 | 33% | 6 | 67% | 4 | 31% | 2 | 20% | |
Lymphovascular invasion | 7 | 78% | 3 | 67% | 10 | 77% | 8 | 80% | 0.912 ^1 |
Perineural invasion | 9 | 100% | 8 | 89% | 13 | 100% | 10 | 100% | ^ 1 |
Patients with isolated local recurrence (n=5) as well as patients with inadequate follow-up (n=3) are not shown.
Biliary obstruction was defined by the presence of either (a) clinical/biochemical (based on abnormal total bilirubin) evidence of jaundice, or (b) preoperative biliary drainage procedure for the relief of biliary obstruction.
Statistical tests:
Pearson’s %;
ANOVA;
Kruskal-Wallis;
Linear-by-Linear Association